Tissue Sealants and Tissue Adhesive Market: By Type (Natural Biological Sealants & Adhesives, Synthetic and Semi-Synthetic Sealants & Adhesives), By Indication (Tissue Sealing & Hemostasis, Tissue Engineering), And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
Tissue Sealants and Tissue Adhesive Market: By Type (Natural Biological Sealants & Adhesives, Synthetic and Semi-Synthetic Sealants & Adhesives), By Indication (Tissue Sealing & Hemostasis, Tissue Engineering), And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
PRODUCT OVERVIEW
Instruments used in surgical operations include surgical sealant and adhesive. Gripping, dissecting, occluding, and retracting are all possible using clamps. Hemostat clamps, aortic vascular clamps, bulldog forceps, and needle holders are only a few examples. During surgery, these clamps are usually employed to hold or grip tissue or blood arteries. Hemostat is a tiny ratchet-locking clamp used to grip blood vessels before cutting them apart. It can be curved or straight, making it useful for delicate dissection around vessels. Hemostatic forceps have the appearance of scissors.
MARKET HIGHLIGHTS
The global Tissue Sealants and Tissue Adhesive Market is expected to project a notable CAGR of 8% in 2031.
Global Tissue Sealants and Tissue Adhesive Market to surpass USD 4.6 billion by 2031 from USD 2.2 billion in 2021 at a CAGR of 8% in the coming years, i.e., 2021-2031. Factors such as the rise in the number of aesthetic, laparoscopic, and cardiac operations; the rise in various cancer kinds that necessitated surgical procedures; and the development of novel surgical tools by a large number of major players. Furthermore, as the prevalence of orthopedic problems rises, so does the demand for surgical sealants and adhesives to reduce surgical injuries, which is expected to drive market expansion.
GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET: SEGMENTS
Natural Biological Sealants and Adhesives segment is expected to grow with the highest CAGR during 2021-31
The global Tissue Sealants and Tissue Adhesive Market is segmented on the basis of type into Natural Biological Sealants and Adhesives, and Synthetic and Semi-Synthetic Sealants and Adhesives. Due to increased R&D activities in the pharmaceutical & medical device industry, a rise in demand for use in surgical procedures, and a surge in adoption of surgical instruments, the natural biological sealants, and adhesives sector dominated the industry in the previous years, and this trend is projected to continue in the forecast period as well.
Tissue Sealing & Hemostasis segment is expected to grow with the highest CAGR during 2021-31
Global Tissue Sealants and Tissue Adhesive Market is classified on the basis of Indication into Tissue Sealing & Hemostasis, and Tissue Engineering. Due to an increase in the number of cosmetic surgeries, a rise in the number of cardiac disorders, and an increase in demand for surgical sealants and adhesives to reduce surgical injuries, the tissue sealing and hemostasis segment was the leading contributor in 2020 and is expected to continue to lead during the forecast period.
MARKET DYNAMICS
Drivers
The Growing Number of Surgeries and Increasing Cases of Orthopedic Disorders
Increasing Geriatric Population suffering from Cardiac Diseases
Restraint
Strict Regulatory Policies and Significantly Priced Products
GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET:
Key Players
PRODUCT OVERVIEW
Instruments used in surgical operations include surgical sealant and adhesive. Gripping, dissecting, occluding, and retracting are all possible using clamps. Hemostat clamps, aortic vascular clamps, bulldog forceps, and needle holders are only a few examples. During surgery, these clamps are usually employed to hold or grip tissue or blood arteries. Hemostat is a tiny ratchet-locking clamp used to grip blood vessels before cutting them apart. It can be curved or straight, making it useful for delicate dissection around vessels. Hemostatic forceps have the appearance of scissors.
MARKET HIGHLIGHTS
The global Tissue Sealants and Tissue Adhesive Market is expected to project a notable CAGR of 8% in 2031.
Global Tissue Sealants and Tissue Adhesive Market to surpass USD 4.6 billion by 2031 from USD 2.2 billion in 2021 at a CAGR of 8% in the coming years, i.e., 2021-2031. Factors such as the rise in the number of aesthetic, laparoscopic, and cardiac operations; the rise in various cancer kinds that necessitated surgical procedures; and the development of novel surgical tools by a large number of major players. Furthermore, as the prevalence of orthopedic problems rises, so does the demand for surgical sealants and adhesives to reduce surgical injuries, which is expected to drive market expansion.
GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET: SEGMENTS
Natural Biological Sealants and Adhesives segment is expected to grow with the highest CAGR during 2021-31
The global Tissue Sealants and Tissue Adhesive Market is segmented on the basis of type into Natural Biological Sealants and Adhesives, and Synthetic and Semi-Synthetic Sealants and Adhesives. Due to increased R&D activities in the pharmaceutical & medical device industry, a rise in demand for use in surgical procedures, and a surge in adoption of surgical instruments, the natural biological sealants, and adhesives sector dominated the industry in the previous years, and this trend is projected to continue in the forecast period as well.
Tissue Sealing & Hemostasis segment is expected to grow with the highest CAGR during 2021-31
Global Tissue Sealants and Tissue Adhesive Market is classified on the basis of Indication into Tissue Sealing & Hemostasis, and Tissue Engineering. Due to an increase in the number of cosmetic surgeries, a rise in the number of cardiac disorders, and an increase in demand for surgical sealants and adhesives to reduce surgical injuries, the tissue sealing and hemostasis segment was the leading contributor in 2020 and is expected to continue to lead during the forecast period.
MARKET DYNAMICS
Drivers
The Growing Number of Surgeries and Increasing Cases of Orthopedic Disorders
Increasing Geriatric Population suffering from Cardiac Diseases
Restraint
Strict Regulatory Policies and Significantly Priced Products
GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET:
Key Players
- Baxter International, Inc.
- CryoLife, Inc.
- C.R. Bard, Inc.
- Medtronic PLC
- B. Braun Melsungen AG
- Cohera Medical, Inc.
- Ethicon, Inc. [J&J]
- Mallinckrodt plc
- Cardinal Health
- Integra LifeSciences
- Other Prominent Players
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
2 GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 AVERAGE PRICING ANALYSIS
5 MACRO-ECONOMIC INDICATORS
6 MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9 RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Mexico, Brazil, and Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (United Kingdom, France, Germany, Italy, Spain, Switzerland, and Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (India, China, South Korea, Japan, and Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (North Africa, South Africa, and Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Type: Market Share (2020-2031F)
12.2.1. Natural Biological Sealants & Adhesives, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Synthetic and Semi-Synthetic Sealants & Adhesives, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Indication: Market Share (2020-2031F)
12.3.1. Tissue Sealing & Hemostasis, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Tissue Engineering, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 COMPANY PROFILE
13.1. Baxter International, Inc.
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. CryoLife, Inc.
13.3. C.R. Bard, Inc.
13.4. Medtronic PLC
13.5. B. Braun Melsungen AG
13.6. Cohera Medical, Inc.
13.7. Ethicon, Inc. [J&J]
13.8. Mallinckrodt plc
13.9. Cardinal Health
13.10. Integra LifeSciences
13.11. Other Prominent Players
14 CONSULTANT RECOMMENDATION
The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2 GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 AVERAGE PRICING ANALYSIS
5 MACRO-ECONOMIC INDICATORS
6 MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9 RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 GLOBAL TISSUE SEALANTS AND TISSUE ADHESIVE MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Mexico, Brazil, and Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (United Kingdom, France, Germany, Italy, Spain, Switzerland, and Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (India, China, South Korea, Japan, and Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (North Africa, South Africa, and Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Type: Market Share (2020-2031F)
12.2.1. Natural Biological Sealants & Adhesives, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Synthetic and Semi-Synthetic Sealants & Adhesives, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Indication: Market Share (2020-2031F)
12.3.1. Tissue Sealing & Hemostasis, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Tissue Engineering, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 COMPANY PROFILE
13.1. Baxter International, Inc.
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. CryoLife, Inc.
13.3. C.R. Bard, Inc.
13.4. Medtronic PLC
13.5. B. Braun Melsungen AG
13.6. Cohera Medical, Inc.
13.7. Ethicon, Inc. [J&J]
13.8. Mallinckrodt plc
13.9. Cardinal Health
13.10. Integra LifeSciences
13.11. Other Prominent Players
14 CONSULTANT RECOMMENDATION
The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
